STOK 15.22 (+0.66%)
US86150R1077BiotechnologyBiotechnology

Stoke Therapeutics (STOK) Stock Highlights

15.22 | +0.66%
2024-09-19 03:50:11
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.

Statistics

Range Today
15.02 15.86
Volume Today 821.9K
Range 1 Year
3.35 17.58
Volume 1 Year 160.58M
Range 3 Year
3.35 33.06
Volume 3 Year 308.91M
Range 10 Year
3.35 71.58
Volume 10 Year 404.48M

Highlights

Market Capitalization 761.81M (small)
Floating Shares 31.77M
Current Price 15.22
Price To Earnings -6.32
Price To Revenue 32.04
Price To Book 3.12
Earnings Per Share -2.17
Payout Ratio 0%

Performance

Latest +0.66%
1 Month +4.03%
3 Months -2.19%
6 Months +137.81%
1 Year +204.4%
3 Years -38.36%
5 Years -37.67%
10 Years -44.06%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.